Stocks and Investing Stocks and Investing
Thu, August 1, 2024

Charles Duncan Maintained (VNDA) at Buy with Increased Target to $13 on, Aug 1st, 2024


Published on 2024-10-28 13:03:18 - WOPRAI, Charles Duncan
  Print publication without navigation


Charles Duncan of Cantor Fitzgerald, Maintained "Vanda Pharmaceuticals Inc." (VNDA) at Buy with Increased Target from $11 to $13 on, Aug 1st, 2024.

Charles, nor any peers, have made any analyst calls on VNDA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources